Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.
Stenger D, Stief TA, Kauferle T, Willier S, Rataj F, Schober K, Vick B, Lotfi R, Wagner B, Grunewald TGP, Kobold S, Busch DH, Jeremias I, Blaeschke F, Feuchtinger TF
Blood. 2020 Jun 1. pii: 460603. doi: 10.1182/blood.2020005185.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.